InvestorsHub Logo
Followers 23
Posts 1671
Boards Moderated 0
Alias Born 09/04/2009

Re: None

Thursday, 12/29/2016 1:28:43 PM

Thursday, December 29, 2016 1:28:43 PM

Post# of 73422
NEWS

On January 31, 2014, the Company purchased an exclusive license (the "License") on the patent pending technology from Dr. Howard Phillips represented by US Patent #20130190274. The Company amended the License on September 30, 2016 such that it is now a non-exclusive distribution and licensing agreement.
Viabecline is currently listed with the FDA. Detailed product information is available online by accessing the Government website, DailyMed.

p.7

http://www.otcmarkets.com/financialReportViewer?symbol=VDRM&id=164573